Cargando…

The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based Review

BACKGROUND: Lichen Planus (LP) is a dermatological disorder characterized by violaceous papules that affect the cutaneous region, nails, scalp, and mucous membranes. Current molecular and clinical studies point to the Janus Kinase-signal transducer and activator of transcription (JAK-STAT) pathway a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abduelmula, Abrahim, Bagit, Ahmed, Mufti, Asfandyar, Yeung, Katie C.Y., Yeung, Jensen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291104/ https://www.ncbi.nlm.nih.gov/pubmed/36815857 http://dx.doi.org/10.1177/12034754231156100

Ejemplares similares

Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based Review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

Drugs Associated With the Development of Palmoplantar Keratoderma: A Systematic Review
por: Mirali, Sara, et al.
Publicado: (2021)

Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Treatment outcomes in patients with papuloerythroderma of Ofuji: A systematic review
por: Mufti, Asfandyar, et al.
Publicado: (2021)

A Systematic Review Characterizing Psoriatic Arthritis Onset and Exacerbation in Patients Receiving Biologic Therapy
por: Sachdeva, Muskaan, et al.
Publicado: (2022)

Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Biologic therapy for refractory pemphigoid gestationis: An evidence-based systematic review
por: Sood, Siddhartha, et al.
Publicado: (2023)

Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class
por: Bagit, Ahmed, et al.
Publicado: (2023)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

Coexistence of nail lichen planus and lichen planus pigmentosus
por: Lemes, Luciana Rodino, et al.
Publicado: (2016)

Lichen Planus
por: Boch, Katharina, et al.
Publicado: (2021)

Lichen planus specific antigen and antibodies--in a patient with generalized lichen planus.
por: Lee, C. W., et al.
Publicado: (1987)

Are patients with lichen planus really prone to urolithiasis? Lichen planus and urolithiasis
por: Oguz, Ural, et al.
Publicado: (2016)

Treatment outcomes of biologics and small molecules for chronic hand eczema: An evidence-based systematic review
por: Sood, Siddhartha, et al.
Publicado: (2023)

Lichen planus pigmentosus
por: Bourra, Hayat, et al.
Publicado: (2013)

Lichen planus pigmentosus
por: Bourra, Hayat, et al.
Publicado: (2013)

Esophageal lichen planus
por: de Oliveira, Janine Pichler, et al.
Publicado: (2015)

Blaschkoid lichen planus: Throwing a “curve” in the nomenclature of linear lichen planus
por: Criscito, Maressa C., et al.
Publicado: (2020)

Lichen Planus Pigmentosus Inversus: A Rare Subvariant of Lichen Planus Pigmentosus
por: Guertler, Anne, et al.
Publicado: (2021)

Bullous Lichen Planus vs Lichen Planus Pemphigoides: A Diagnostic Dilemma
por: Tripathy, Durga M., et al.
Publicado: (2022)

Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

Oral lichen planus - Review on etiopathogenesis
por: Srinivas, K., et al.
Publicado: (2011)

Reply to: “Skin damage among health care workers managing coronavirus disease 2019”
por: Maliyar, Khalad, et al.
Publicado: (2020)

Dermatology: how to manage psoriasis and recognize differences in pathophysiology and presentation in patients with skin of colour
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors
por: Alharbi, Ahmad, et al.
Publicado: (2022)

Lichen Planus and Lichen Planus Pigmentosus Inversus Following COVID-19 Vaccine in Dark Phototype Patients
por: Gil-Quiñones, S.R., et al.
Publicado: (2023)

Serum Levels of IL-22 in Patients with Oral Lichen Planus and Cutaneous Lichen Planus
por: Mardani, Maryam, et al.
Publicado: (2020)

Eruptive Seborrheic Keratoses Are Associated With a Co-Occurring Malignancy in the Majority of Reported Cases: A Systematic Review
por: Mirali, Sara, et al.
Publicado: (2021)

Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
por: Georgakopoulos, Jorge R., et al.
Publicado: (2020)

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
por: Le, Michelle, et al.
Publicado: (2021)

IMATINIB INDUCED LICHEN PLANUS
por: Sudha, R, et al.
Publicado: (2011)

Oral Lichen Planus in Children
por: Mohan Das, Usha, et al.
Publicado: (2009)

Mediators of Pruritus in Lichen Planus
por: Welz-Kubiak, Kalina, et al.
Publicado: (2013)

Lichen planus pigmentosus inversus
por: Barros, Hugo Rocha, et al.
Publicado: (2013)

Ulcerative Lichen Planus in Childhood
por: Padmini, Chiyadu, et al.
Publicado: (2013)

Oral lichen planus: An overview
por: Krupaa, R. Jayasri, et al.
Publicado: (2015)

Vulvar lichen planus pemphigoides()()
por: Loyal, J., et al.
Publicado: (2017)

Palmoplantar Lesions of Lichen Planus
por: Sinha, Surabhi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lev365iu7s27ljk0ei4c392vjs